VYNE Therapeutics Inc. — SC 13G/A Filings
16 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by VYNE Therapeutics Inc. (VYNE), sorted by most recent first. Each row links to the full filing on EdgarLookup. VYNE Therapeutics Inc. has filed 16 SC 13G/A documents with the SEC since 2013. To view all SEC filings by VYNE Therapeutics Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
4
4/A
424B2
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-24-098334 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023931 | Feb 14, 2024 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-24-009367 | Feb 2, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-042521 | Feb 15, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-21-256396 | Aug 25, 2021 | — |
| SC 13G/A | — | 0000834237-21-008516 | Jul 12, 2021 | — |
| SC 13G/A | — | 0001172661-21-000719 | Feb 16, 2021 | — |
| SC 13G/A | SC 13G/A | 0001193125-21-044738 | Feb 16, 2021 | — |
| SC 13G/A | SCHEDULE 13G (AMENDMENT #1) | 0000899140-21-000303 | Feb 16, 2021 | — |
| SC 13G/A | — | 0001172661-21-000675 | Feb 16, 2021 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-20-014713 | Jun 11, 2020 | — |
| SC 13G/A | — | 0001172661-20-000846 | Feb 14, 2020 | — |
| SC 13G/A | NONE | 0001567619-20-002059 | Feb 4, 2020 | — |
| SC 13G/A | — | 0000930413-19-000570 | Feb 14, 2019 | — |
| SC 13G/A | — | 0000315066-19-001157 | Feb 13, 2019 | — |
| SC 13G/A | SC 13G/A | 0001193125-19-003563 | Jan 7, 2019 | — |